US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 29 for "Therapeutic antigen binding proteins specific for CD93 and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,469, issued on July 29, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Therapeutic antigen binding proteins specific for CD93 and methods of use thereof" was invented by Ravindra Majeti (Palo Alto, Calif.), Crystal Mackall (Stanford, Calif.), Jie Liu (Palo Alto, Calif.), Robbie Majzner (Palo Alto, Calif.), Rebecca Richards (Portola Valley, Calif.) and Wan-Jen Hong (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antigen binding domain polypeptides (ABD) specific for human CD93 are provided, which ABD may be formatted as antibodies, as chimeric antigen receptors, and the like. ...